Page last updated: 2024-09-04

interleukin 1beta (193-195) and adenosine

interleukin 1beta (193-195) has been researched along with adenosine in 1 studies

Compound Research Comparison

Studies
(interleukin 1beta (193-195))
Trials
(interleukin 1beta (193-195))
Recent Studies (post-2010)
(interleukin 1beta (193-195))
Studies
(adenosine)
Trials
(adenosine)
Recent Studies (post-2010) (adenosine)
180232,5361,0758,930

Protein Interaction Comparison

ProteinTaxonomyinterleukin 1beta (193-195) (IC50)adenosine (IC50)
high affinity choline transporter 1 isoform aHomo sapiens (human)0.3851
Sodium/nucleoside cotransporter 1Homo sapiens (human)5.5
Sodium/nucleoside cotransporter 2Homo sapiens (human)5.5
Adenosine receptor A3Homo sapiens (human)0.0011
Adenosine receptor A1Homo sapiens (human)0.0023
Equilibrative nucleoside transporter 1Homo sapiens (human)63
Solute carrier family 28 member 3Homo sapiens (human)3.3

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
An, XM; Leung, WK; Lv, MM; Ren, TH; Seto, WK1

Other Studies

1 other study(ies) available for interleukin 1beta (193-195) and adenosine

ArticleYear
Activation of adenosine A3 receptor inhibits inflammatory cytokine production in colonic mucosa of patients with ulcerative colitis by down-regulating the nuclear factor-kappa B signaling.
    Journal of digestive diseases, 2020, Volume: 21, Issue:1

    Topics: Adenosine; Colitis, Ulcerative; Colon; Cytokines; Down-Regulation; Humans; Inflammation; Interleukin-1beta; Intestinal Mucosa; NF-kappa B; Peptide Fragments; Purinergic P1 Receptor Agonists; Receptor, Adenosine A3; Signal Transduction; Tumor Necrosis Factor-alpha; Up-Regulation

2020